Specification: |
The 4-Imidazolidinecarboxylicacid,3-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-,hydrochloride (1:1), (4S)- , with the CAS register number 89396-94-1, has the systematic name of 4-Imidazolidinecarboxylic acid, 3-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4S-(3(R*(R*)),4R*))- . And it is also known to us as (s)-3-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-1-methyl-2-oxo-imidazolidine-4-carboxylic acid ; imidaprilhydrochloride ; 4-imidazolidinecarboxylic acid, 3-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-, monohydrochloride, (4s)-;novaloc;ta 6366 ; tanapril ; (s)-3-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-1-methyl-2-oxo-imidazolidine-4-carboxylic acid: hydrochloride .
The characteristics of this chemical are as below:(1)ACD/BCF (pH 5.5): 1 ; (2)ACD/BCF (pH 7.4): 1 ; (3)ACD/KOC (pH 5.5): 1 ; (4) ACD/KOC (pH 7.4): 1 ; (5)#H bond acceptors: 9 ; (6)#H bond donors: 2 ; (7)#Freely Rotating Bonds: 10 ; (8)Polar Surface Area: 96.46 ; (9)Flash Point: 302.8 °C ; (10)Enthalpy of Vaporization: 90.88 kJ/mol ; (11)Boiling Point: 577 °C at 760 mmHg ; (12)Vapour Pressure: 3.71E-14 mmHg at 25°C.
This kind of chemical could be used in many fields, such as angiotensin-converting enzyme inhibitors, antihypertensive agents, cardiovascular agents, drug / therapeutic agent, enzyme inhibitors and protease inhibitors.
You could also convert the following data information into the molecular structure:
SMILES:O=C(O)[C@H]2N(C(=O)[C@@H](N[C@H](C(=O)OCC)CCc1ccccc1)C)C(=O)N(C)C2.Cl
InChI:InChI=1/C20H27N3O6.ClH/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28;/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26);1H/t13-,15-,16-;/m0./s1
InChIKey:LSLQGMMMRMDXHN-GEUPQXMHBC
As to the market information, there are many supplier in China, such as LGM Pharmaceuticals Inc. Hangzhou Sunny Chemical Co., Ltd. and Link Chemicals Co.,Ltd.
In addition, you could get the toxicity information:
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
dog |
LD50 |
oral |
> 1800mg/kg (1800mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
mouse |
LD50 |
intravenous |
> 500mg/kg (500mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
mouse |
LD50 |
oral |
> 5gm/kg (5000mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
mouse |
LD50 |
subcutaneous |
> 1gm/kg (1000mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
rat |
LD50 |
intravenous |
> 500mg/kg (500mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
rat |
LD50 |
oral |
3536mg/kg (3536mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
rat |
LD50 |
subcutaneous |
> 1gm/kg (1000mg/kg) |
|
Drugs in Japan Vol. -, Pg. 165, 1995. |
|